Vimarsana
Biggest News Aggregation in the World

Page 14 - Active Ingredients News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Active Ingredients. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Active Ingredients Today - Breaking & Trending Today

Dr. Reddy's Laboratories Limited (NYSE:RDY) Receives Average Recommendation of "Hold" from Brokerages - Vimarsana News

Dr. Reddy's Laboratories Limited (NYSE:RDY) Receives Average Recommendation of "Hold" from Brokerages

Shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Get Free Report) have been assigned a consensus recommendation of “Hold” from the six ratings firms that are currently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and two have given a […]

US FDA warns online vendors to stop selling unapproved weight-loss drugs - Vimarsana News

US FDA warns online vendors to stop selling unapproved weight-loss drugs

The U.S. Food and Drug Administration (FDA) on Tuesday published letters warning two online vendors to stop selling unapproved versions of semaglutide and tirzepatide, the active ingredients in popular GLP-1 class medications including Novo Nordisk’s powerful weight-loss drug Wegovy. In the letters sent to Semaspace and Gorilla Healing on Oct. 2, the FDA said the only approved semaglutide products were Wegovy and Novo’s diabetes drugs Ozempic and Rybelsus.

Source: yahoo.com
Brokerages Set Dr. Reddy's Laboratories Limited (NYSE:RDY) Target Price at $70.00 - Vimarsana News

Brokerages Set Dr. Reddy's Laboratories Limited (NYSE:RDY) Target Price at $70.00

Dr. Reddy’s Laboratories Limited (NYSE:RDY – Get Free Report) has earned an average rating of “Hold” from the six ratings firms that are presently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and two have given a buy recommendation […]

Best Supplements for Hair Growth in 2023 - Vimarsana News

Best Supplements for Hair Growth in 2023

Branded content. Us Weekly has affiliate partnerships so we may receive compensation for some links to products and services. It’s normal to lose around

Head to Head Analysis: LAVA Therapeutics (NASDAQ:LVTX) versus Dr. Reddy's Laboratories (NYSE:RDY) - Vimarsana News

Head to Head Analysis: LAVA Therapeutics (NASDAQ:LVTX) versus Dr. Reddy's Laboratories (NYSE:RDY)

LAVA Therapeutics (NASDAQ:LVTX – Get Free Report) and Dr. Reddy’s Laboratories (NYSE:RDY – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability and risk. Earnings & Valuation This table compares LAVA […]